Matthew E Korenberg insider trades

Open-market stock purchases and sales by Matthew E Korenberg, CFO, Treasurer at Palvella Therapeutics, Inc, from SEC Form 4 filings since Aug 6, 2015.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +38%.

Recent trades

DateStockTradeValue
Jun 12, 2026PVLA Palvella Therapeutics, IncBought (not open market)—
Jun 4, 2026LFCR Lifecore Biomedical, Inc \de\Bought (not open market)—
Feb 5, 2026PVLA Palvella Therapeutics, IncBought (not open market)—

Companies traded

  • PVLA Palvella Therapeutics, Inc: other filings, last Jun 12, 2026
  • LFCR Lifecore Biomedical, Inc \de\: other filings, last Jun 4, 2026
  • LGND Ligand Pharmaceuticals Inc: 2 buys, 15 sales, last Sep 23, 2024
  • QLGN Qualigen Therapeutics, Inc: other filings, last Jul 11, 2022

Get free alerts when Matthew E Korenberg files a new trade →